US Stock MarketDetailed Quotes

AEON AEON Biopharma

Watchlist
  • 1.780
  • +0.090+5.33%
Close May 24 16:00 ET
  • 1.780
  • 0.0000.00%
Post 19:51 ET
69.64MMarket Cap-171P/E (TTM)

About AEON Biopharma Company

AEON Biopharma, Inc. is a biopharmaceutical company. It engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.

Company Profile

SymbolAEON
Company NameAEON Biopharma
Listing DateJul 24, 2023
Founded2012
CEOMr. Marc Forth
MarketAMEX
Employees10
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5 Park Plaza,Suite 1750
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92614
Phone1-949-354-6499
Websitehttp://www.aeonbiopharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Marc Forth
  • Director, President, Chief Executive Officer and Principal Financial Officer
  • 3.98M
  • Alexander Blair Wilson
  • Executive Vice President, Chief Legal Officer and Corporate Secretary
  • 1.40M
  • Dr. Chad Oh, M.D.
  • Chief Medical Officer
  • 1.65M
  • Jennifer Sy
  • Vice President, Corporate Controller and Principal Accounting Officer
  • --
  • Jost Fischer
  • Chairman of the Board
  • 862.46K
  • Robert J. Palmisano
  • Director
  • 197.87K
  • Shelley B. Thunen
  • Director
  • 198.86K
  • Seong-soo Park
  • Director
  • --
  • Seongsoo Park
  • Director
  • --
  • Dr. Eric G. Carter,M.D.,PhD
  • Independent Director
  • 216.91K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg